Source: Pioneer Press
Posted: September 6, 2007 11:09:11 PM CDT
Summary:
In the world's first clinical trial of its kind, doctors at the University Of Minnesota infused the "T-regulatory" cells into a leukemia patient to see if they protected her, while a separate stem cell transplant repaired her damaged blood and immune systems. Eventually, U researchers want to use the T-reg cells on their own to treat diseases such as Type 1 diabetes and multiple sclerosis that are caused by overaggressive immune systems.
